Ignite Creation Date:
2025-12-25 @ 12:27 AM
Ignite Modification Date:
2026-02-23 @ 8:06 PM
Study NCT ID:
NCT01629667
Status:
TERMINATED
Last Update Posted:
2017-05-15
First Post:
2012-06-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 2, Randomized Dose-ranging Study to Evaluate the Efficacy of Tralokinumab in Adults With Idiopathic Pulmonary Fibrosis
Sponsor:
MedImmune LLC
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CD-RI-CAT-354-1066
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None